NFKB1 and cholestasis: Moreover, it was recently reported that the activation of hepatocyte NF-κB in parenteral nutrition-associated cholestasis may interfere with FXR and liver X receptor signaling, leading to the transcriptional suppression of bile and sterol transporters, such as MRP2, resulting in cholestasis [131].